1) RFS
无复发生存期
1.
Objective:To evaluate the biological parameters associated with efficiency,relapse free survival(RFS),overall survival(OS) in stageⅡ/Ⅲbreast cancer patients treated by neoadjuvant chemotherapy of docetaxel and Epirubicin.
目的观察多西他赛联合表柔比星(ET)治疗Ⅱ/Ⅲ期乳腺癌疗效、无复发生存期(RFS)、总生存期(OS)及生物学指标的相关性。
2) survival after first relapse
首次复发生存期
3) disease free survival
无病生存期
1.
Objective To investigate the adverse effect,disease free survival and overall survival of dose-dense chemotherapy in postoperative breast cancer patients.
目的观察剂量密度化疗治疗乳腺癌的不良反应及对无病生存期和总生存期的影响。
5) disease-free survival
无病生存期
1.
Impact of adjuvant chemotherapy duration on 3-year disease-free survival of colorectal carcinoma patients after radical resection
术后辅助化疗时间对Ⅲ期和高危Ⅱ期结直肠癌3年无病生存期的影响
2.
Objective: To evaluate whether adjuvant chemotherapy prolongs disease-free survival among patients with completely resected early-stage non–small-cell lung cancer (NSCLC) in elderly patients and the toxicity and safety of the regimen.
结果:两组接受术后辅助化疗后具有相似的无病生存期(P>0。
3.
Influence of perioperative blood transfusion on disease-free survival in non-small cell lung cancer patients;
无病生存期分析采用多因素Cox回归模型 ,并绘制生存曲线 。
补充资料：无复
1.不再，不会再次。 2.指不再有，没有。 3.没有履行。 4.不能恢复。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条